OCUTERRA THERAPEUTICS
OcuTerra Therapeutics, Inc. is developing innovative drugs for ophthalmic diseases for which the current standard of care does not prevent or control the progression of the disease.
OCUTERRA THERAPEUTICS
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2011-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.ocuterratx.com
Status:
Active
Contact:
(617) 701-7382
Email Addresses:
[email protected]
Total Funding:
35 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Organization Schema GoDaddy DNS Typekit
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Synspira
Synspira Therapeutics is focused on developing a rationally designed portfolio of products in cystic fibrosis and other rare diseases.
Tenaya Therapeutics
Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.
Current Employees Featured
Investors List
Robin Hood Ventures
Robin Hood Ventures investment in Series B - OcuTerra Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-04 | OcuTerra Appoints Majid Anderesi, MD, as Vice President of Clinical and Medical Affairs |
Official Site Inspections
http://www.ocuterratx.com Semrush global rank: 3.09 M Semrush visits lastest month: 5.19 K
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "OcuTerra Therapeutics"
OcuTerra Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (617) 701-7382 OcuTerra Therapeutics, Inc. is developing innovative drugs for ophthalmic diseases for which the current standard of care …See details»
Investors — OcuTerra
Investor contact: [email protected] . Learn more about: Our Science News Investors BANNER. Investors CONTENT . 50 Milk Street 16th Floor Boston …See details»
OcuTerra Therapeutics - LinkedIn
OcuTerra Therapeutics | 1,890 followers on LinkedIn. Non-Invasive, Transformational Approach to Treating Retinal Disease | Non-Invasive, Transformational Approach to Treating Retinal Disease.See details»
OcuTerra Therapeutics - Overview, News & Similar companies
Nov 22, 2022 View OcuTerra Therapeutics (www.ocuterratx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well …See details»
OcuTerra - VentureRadar
"OcuTerra Therapeutics, Inc. is a clinical stage company developing innovative drugs to treat ophthalmic diseases for which the current standard of care does not prevent or control the …See details»
OCUTERRA THERAPEUTICS INC Boston MA, 02110 - Company …
Www.ocuterratx.com Company Details. Location Type: Headquarters Industry: Commercial Physical and Biological Research Ownership: Private Year Founded: 2021 Sales Range: …See details»
OcuTerra Therapeutics - 2025 Company Profile - Tracxn
Mar 6, 2025 OcuTerra Therapeutics - Developer of eye drop to treat diabetic eye disease. Raised a total funding of $40.2M over 2 rounds from 2 investors. OcuTerra Therapeutics has …See details»
About OcuTerra — OcuTerra
[email protected] MEDIA CONTACT [email protected]. ABOUT SCIENCE DR:EAM CLINICAL TRIAL PIPELINE INVESTORS NEWS. Ocuterra. 50 Milk Street, Boston, MA, …See details»
OcuTerra Company Profile - Office Locations, Competitors ... - Craft
OcuTerra has 5 employees at their 1 location and $35 m in total funding,. See insights on OcuTerra including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
OcuTerra Therapeutics - PitchBook
OcuTerra Therapeutics General Information Description. Developer of a novel eye drop designed to treat diabetic eye disease. The company's eye drop is an integrin inhibitor purposefully …See details»
OcuTerra Therapeutics Company Profile: Overview and Full News …
OcuTerra Therapeutics is a Massachusetts-based company focused on developing innovative treatments for ophthalmic diseases. Their flagship product, OTT166, is administered as a …See details»
Leadership — OcuTerra
[email protected] MEDIA CONTACT [email protected]. ABOUT SCIENCE DR:EAM CLINICAL TRIAL PIPELINE INVESTORS NEWS. Ocuterra. 50 Milk Street, Boston, MA, …See details»
OcuTerra | VentureRadar
OcuTerra Therapeutics, Inc. is a clinical stage company developing innovative drugs to treat ophthalmic diseases for which the current standard of... ... Find out ...See details»
OcuTerra Appoints Majid Anderesi, MD, as Vice President of …
Apr 4, 2022 www.ocuterratx.com. Contacts. MacDougall Advisors Nicholas Chang [email protected] (781) 235-3060 Contacts. MacDougall Advisors Nicholas Chang …See details»
OcuTerra Therapeutics to Present at 42nd Annual J.P. Morgan …
Jan 4, 2024 www.ocuterratx.com. Contacts. MacDougall Advisors Carolyn Noyes [email protected] 781-235-3060 Release Summary.See details»
News - OcuTerra
Nov 9, 2021 [email protected] MEDIA CONTACT [email protected]. ABOUT SCIENCE DR:EAM CLINICAL TRIAL PIPELINE INVESTORS NEWS. Ocuterra. 50 Milk …See details»
Pipeline — OcuTerra
[email protected] MEDIA CONTACT [email protected]. ABOUT SCIENCE DR:EAM CLINICAL TRIAL PIPELINE INVESTORS NEWS. Ocuterra. 50 Milk Street, Boston, MA, …See details»
CEO Quick Takes: OIS Catches Up with OcuTerra, Neurotech, Notal …
The depth of ophthalmology expertise at the organization is hard to find, he says, and it enables the company to offer comprehensive, high-touch services to its clients. ... OcuTerra …See details»
Science - OcuTerra
[email protected] MEDIA CONTACT [email protected]. ABOUT SCIENCE DR:EAM CLINICAL TRIAL PIPELINE INVESTORS NEWS. Ocuterra. 50 Milk Street, Boston, MA, …See details»